Building novel binding ligands to B7.1 and B7.2 based on human antibody single variable light chain domains.
暂无分享,去创建一个
S E Hufton | J. Desmet | T. van den Beucken | E. Sablon | S. Hufton | N. van Neer | L. Celis | H. Hoogenboom | T van den Beucken | N van Neer | E Sablon | J Desmet | L Celis | H R Hoogenboom
[1] W. Stemmer. Rapid evolution of a protein in vitro by DNA shuffling , 1994, Nature.
[2] E Ohage,et al. Intrabody construction and expression. I. The critical role of VL domain stability. , 1999, Journal of molecular biology.
[3] H R Hoogenboom,et al. By-passing immunization. Human antibodies from V-gene libraries displayed on phage. , 1991, Journal of molecular biology.
[4] J. Gribben,et al. Complete blockade of B7 family-mediated costimulation is necessary to induce human alloantigen-specific anergy: a method to ameliorate graft-versus-host disease and extend the donor pool. , 1996, Blood.
[5] P. Linsley,et al. Complementarity determining region 1 (CDR1)- and CDR3-analogous regions in CTLA-4 and CD28 determine the binding to B7-1 , 1994, The Journal of experimental medicine.
[6] C. Balagué,et al. Replicative adenoviruses for cancer therapy , 2000, Nature Biotechnology.
[7] F. Denizot,et al. A new member of the immunoglobulin superfamily—CTLA-4 , 1987, Nature.
[8] H R Hoogenboom,et al. Natural and designer binding sites made by phage display technology. , 2000, Immunology today.
[9] D. Cahill,et al. Protein and antibody arrays and their medical applications. , 2001, Journal of immunological methods.
[10] T. Yokota,et al. Rapid tumor penetration of a single-chain Fv and comparison with other immunoglobulin forms. , 1992, Cancer research.
[11] J. Allison,et al. Enhancement of Antitumor Immunity by CTLA-4 Blockade , 1996, Science.
[12] S E Hufton,et al. Direct selection of a human antibody fragment directed against the tumor T-cell epitope HLA-A1-MAGE-A1 from a nonimmunized phage-Fab library. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[13] P. Linsley,et al. CTLA-4 is a second receptor for the B cell activation antigen B7 , 1991, The Journal of experimental medicine.
[14] K. Constantine,et al. Redefining the minimal antigen-binding fragment , 1996, Nature Structural Biology.
[15] P. Hudson,et al. Recombinant antibody fragments. , 1998, Current opinion in biotechnology.
[16] S. Tonegawa. Somatic generation of antibody diversity , 1983, Nature.
[17] K. Constantine,et al. Solution structure of human CTLA-4 and delineation of a CD80/CD86 binding site conserved in CD28 , 1997, Nature Structural Biology.
[18] P. Schuck,et al. An antibody single-domain phage display library of a native heavy chain variable region: isolation of functional single-domain VH molecules with a unique interface. , 1999, Journal of molecular biology.
[19] E. Söderlind,et al. Domain libraries: synthetic diversity for de novo design of antibody V-regions. , 1995, Gene.
[20] L. Wyns,et al. Camel Single-domain Antibodies as Modular Building Units in Bispecific and Bivalent Antibody Constructs* , 2001, The Journal of Biological Chemistry.
[21] C. Linge,et al. Interactions of CD80 and CD86 with CD28 and CTLA4. , 1996, Journal of immunology.
[22] P. Linsley,et al. Covalent Dimerization of CD28/CTLA-4 and Oligomerization of CD80/CD86 Regulate T Cell Costimulatory Interactions* , 1996, The Journal of Biological Chemistry.
[23] S. Larson,et al. In vivo fate of monoclonal antibody B72.3 in patients with colorectal cancer. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[24] A. Cattaneo,et al. The selection of intracellular antibodies. , 1998, Trends in biotechnology.
[25] T. Saito. Negative regulation of T cell activation. , 1998, Current opinion in immunology.
[26] J. Desmet,et al. Development and application of cytotoxic T lymphocyte‐associated antigen 4 as a protein scaffold for the generation of novel binding ligands , 2000, FEBS letters.
[27] J. Barnikow,et al. Intrabody construction and expression. II. A synthetic catalytic Fv fragment. , 1999, Journal of molecular biology.
[28] P. Linsley,et al. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg. , 1992, Science.
[29] P. Linsley,et al. CD28 engagement by B7/BB-1 induces transient down-regulation of CD28 synthesis and prolonged unresponsiveness to CD28 signaling. , 1993, Journal of immunology.
[30] D. Christiani,et al. Inhibition of T cell costimulation abrogates airway hyperresponsiveness in a murine model. , 1996, The Journal of clinical investigation.
[31] C. Milstein,et al. The Dynamic Nature of the Antibody Repertoire , 1988, Immunological reviews.
[32] Hennie R. Hoogenboom,et al. A Large Non-immunized Human Fab Fragment Phage Library That Permits Rapid Isolation and Kinetic Analysis of High Affinity Antibodies* , 1999, The Journal of Biological Chemistry.
[33] P. Linsley,et al. CD80 (B7-1) Binds Both CD28 and CTLA-4 with a Low Affinity and Very Fast Kinetics , 1997, The Journal of experimental medicine.
[34] L. Riechmann,et al. Antibody VH Domains as Small Recognition Units , 1995, Bio/Technology.
[35] P. Linsley,et al. The role of the CD28 receptor during T cell responses to antigen. , 1993, Annual review of immunology.
[36] J. Bluestone,et al. CD28/B7 system of T cell costimulation. , 1996, Annual review of immunology.
[37] P. T. Jones,et al. Binding activities of a repertoire of single immunoglobulin variable domains secreted from Escherichia coli , 1989, Nature.
[38] G. Oster,et al. Theoretical studies of clonal selection: minimal antibody repertoire size and reliability of self-non-self discrimination. , 1979, Journal of theoretical biology.
[39] P. Linsley,et al. Treatment of murine lupus with CTLA4Ig. , 1994, Science.
[40] S. Muyldermans,et al. Naturally occurring antibodies devoid of light chains , 1993, Nature.